• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的血清溶菌酶

Serum lysozyme in inflammatory bowel disease.

作者信息

Nugent F W, Mallari R, George H, Ridley N

出版信息

Gastroenterology. 1976 Jun;70(6):1014-6.

PMID:1269861
Abstract

Serum lysozyme (muramidase) concentrations were measured in three groups of patients: control, ulcerative colitis and proctitis, and Crohn's disease. The mean +/-SD for each group was: control, 7 +/- 2; ulcerative colitis and proctitis, 7 +/- 2; and Crohn's disease, 10 +/- 4. Although a significant difference was seen between values in patients with Crohn's disease and values observed in those with ulcerative colitis or control patients, an important overlap was found between these groups. Further studies are necessary to explain the disparate results between this study and previous reports.

摘要

对三组患者测定了血清溶菌酶(胞壁质酶)浓度:对照组、溃疡性结肠炎和直肠炎组以及克罗恩病组。每组的均值±标准差分别为:对照组,7±2;溃疡性结肠炎和直肠炎组,7±2;克罗恩病组,10±4。虽然克罗恩病患者的值与溃疡性结肠炎患者或对照组患者的值之间存在显著差异,但在这些组之间发现了重要的重叠。需要进一步研究来解释本研究与先前报告之间不同的结果。

相似文献

1
Serum lysozyme in inflammatory bowel disease.炎症性肠病中的血清溶菌酶
Gastroenterology. 1976 Jun;70(6):1014-6.
2
Serum lysozyme in Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎中的血清溶菌酶
N Engl J Med. 1975 Feb 20;292(8):395-7. doi: 10.1056/NEJM197502202920805.
3
Indices of granulocyte activity in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中粒细胞活性指标
Dan Med Bull. 1977 Apr;24(2):72-6.
4
The diagnostic value of serum lysozyme activity in inflammatory bowel disease.血清溶菌酶活性在炎症性肠病中的诊断价值。
Am J Gastroenterol. 1977 Jul;68(1):71-6.
5
Serum lysozyme in Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎中的血清溶菌酶
Scand J Gastroenterol. 1976;11(2):213-7.
6
Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.信件:克罗恩病和溃疡性结肠炎患者的血清溶菌酶水平
N Engl J Med. 1976 Jan 8;294(2):111. doi: 10.1056/NEJM197601082940214.
7
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.C反应蛋白:炎症性肠病中炎症的预测因子和标志物。一项基于人群的前瞻性研究结果
Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19.
8
Serum lysozyme in inflammatory bowel disease.炎症性肠病中的血清溶菌酶
Gastroenterology. 1976 Mar;70(3):469-71.
9
[The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].[反应蛋白C在溃疡性结肠炎和克罗恩病患者管理中的作用]
Rev Esp Enferm Dig. 1993 Jan;83(1):5-9.
10
Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).胶囊内镜在溃疡性结肠炎和未分类型炎症性肠病(IBDU)中的诊断率。
Endoscopy. 2008 Jan;40(1):30-5. doi: 10.1055/s-2007-995359. Epub 2007 Dec 5.

引用本文的文献

1
Predicting relapses of Crohn's disease. Clouds in the crystal ball.预测克罗恩病的复发。难以预测的前景。
Dig Dis Sci. 1987 Feb;32(2):206-8. doi: 10.1007/BF01297109.
2
Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.克罗恩病和溃疡性结肠炎中的溶菌酶
Am J Dig Dis. 1977 Nov;22(11):995-8. doi: 10.1007/BF01076199.
3
Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.非特异性炎性肠病中血清溶菌酶、血清蛋白及免疫球蛋白的测定
Am J Dig Dis. 1978 Apr;23(4):297-301. doi: 10.1007/BF01072409.
4
Crohn disease. Newer aspects of etiology, diagnosis and therapy.克罗恩病。病因、诊断及治疗的新进展
West J Med. 1978 May;128(5):419-27.
5
Complex nature of serum lysozyme activity: evidence of thermolability in inflammatory bowel disease.血清溶菌酶活性的复杂性质:炎症性肠病中热不稳定性的证据。
J Clin Pathol. 1978 Jan;31(1):39-43. doi: 10.1136/jcp.31.1.39.
6
Serum and tissue lysozyme in leprosy.麻风病中的血清和组织溶菌酶
Infect Immun. 1977 Dec;18(3):847-56. doi: 10.1128/iai.18.3.847-856.1977.
7
Serum lysozyme levels in malignant histiocytosis of the intestine.肠道恶性组织细胞增多症中的血清溶菌酶水平
Gut. 1979 Oct;20(10):854-7. doi: 10.1136/gut.20.10.854.